GURUFOCUS.COM » STOCK LIST » Technology » Software » Genpact Ltd (FRA:35G) » Definitions » Research & Development

Genpact (FRA:35G) Research & Development : €0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Genpact Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Genpact's Research & Development for the three months ended in Mar. 2024 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €0 Mil.

Genpact Research & Development Historical Data

The historical data trend for Genpact's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genpact Research & Development Chart

Genpact Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Genpact Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Genpact Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genpact  (FRA:35G) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Genpact Research & Development Related Terms

Thank you for viewing the detailed overview of Genpact's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Genpact (FRA:35G) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Technology » Software » Genpact Ltd (FRA:35G) » Definitions » Research & Development
Comparable Companies
EXLS CLVT AUR SAIC ASGN KD DXC CNXC GLOB PSN ACN NSE:TCS IBM FI NSE:INFY NSE:HCLTECH FIS XPAR:CAP IT CTSH
Traded in Other Exchanges
G:USA
Address
22 Victoria Street, Canon's Court, Hamilton, BMU, HM 12
Website
https://www.genpact.com
Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. The company is a General Electric spin-off, which is still a large source of revenue for Genpact.

Genpact (FRA:35G) Headlines

No Headlines